BACKGROUND: Most consensus HIV-1-specific cytotoxic T lymphocytes epitopes presented via intensively studied HLA molecules are thought to be known OBJECTIVE: To identify possible novel HIV-1 epitopes for HLA-B27 and HLA-B57; two HLA types which are abundantly studied because of their correlation with slow HIV disease progression. METHODS: HIV-1 consensus subtype B sequences were analysed using peptide prediction programs based on major histocompatibility complex binding, proteasomal cleavage and TAP (transporter associated with antigen processing) transport. Recognition of the novel identified epitopes by cytotoxic T lymphocytes was tested using interferon-gamma ELISpot assay. RESULTS: In total, 22 novel epitopes predicted to be presented by either HLA-B27 or HLA-B57 were selected. Of these, 86% elicited significant immune responses in HIV-1-infected individuals. CONCLUSIONS: These data show that numerous HIV-1 epitopes remain to be identified, and that prediction programs are powerful tools for this purpose.
BACKGROUND: Most consensus HIV-1-specific cytotoxic T lymphocytes epitopes presented via intensively studied HLA molecules are thought to be known OBJECTIVE: To identify possible novel HIV-1 epitopes for HLA-B27 and HLA-B57; two HLA types which are abundantly studied because of their correlation with slow HIV disease progression. METHODS:HIV-1 consensus subtype B sequences were analysed using peptide prediction programs based on major histocompatibility complex binding, proteasomal cleavage and TAP (transporter associated with antigen processing) transport. Recognition of the novel identified epitopes by cytotoxic T lymphocytes was tested using interferon-gamma ELISpot assay. RESULTS: In total, 22 novel epitopes predicted to be presented by either HLA-B27 or HLA-B57 were selected. Of these, 86% elicited significant immune responses in HIV-1-infected individuals. CONCLUSIONS: These data show that numerous HIV-1 epitopes remain to be identified, and that prediction programs are powerful tools for this purpose.
Authors: Rebecca P Payne; Henrik Kløverpris; Jonah B Sacha; Zabrina Brumme; Chanson Brumme; Søren Buus; Stuart Sims; Stephen Hickling; Lynn Riddell; Fabian Chen; Graz Luzzi; Anne Edwards; Rodney Phillips; Julia G Prado; Philip J R Goulder Journal: J Virol Date: 2010-08-04 Impact factor: 5.103
Authors: Coral-Ann M Almeida; Corine Bronke; Steven G Roberts; Elizabeth McKinnon; Niamh M Keane; Abha Chopra; Carl Kadie; Jonathan Carlson; David W Haas; Sharon A Riddler; Richard Haubrich; David Heckerman; Simon Mallal; Mina John Journal: J Immunol Date: 2011-08-05 Impact factor: 5.422
Authors: Henrik N Kloverpris; Anette Stryhn; Mikkel Harndahl; Mary van der Stok; Rebecca P Payne; Philippa C Matthews; Fabian Chen; Lynn Riddell; Bruce D Walker; Thumbi Ndung'u; Søren Buus; Philip Goulder Journal: J Virol Date: 2011-11-16 Impact factor: 5.103
Authors: Daniel T Claiborne; Timothy E Dudek; Colby R Maldini; Karen A Power; Musie Ghebremichael; Edward Seung; Elizabeth F Mellors; Vladimir D Vrbanac; Katharine Krupp; Abigail Bisesi; Andrew M Tager; David M Knipe; Christian L Boutwell; Todd M Allen Journal: J Virol Date: 2019-09-30 Impact factor: 5.103
Authors: Lyle R McKinnon; Xiaojuan Mao; Joshua Kimani; Charles Wachihi; Christina Semeniuk; Mark Mendoza; Binhua Liang; Ma Luo; Keith R Fowke; Francis A Plummer; T Blake Ball Journal: PLoS One Date: 2009-09-11 Impact factor: 3.240
Authors: Marjon Navis; Diana Edo Matas; Andrea Rachinger; Fransje A Koning; Peter van Swieten; Neeltje A Kootstra; Hanneke Schuitemaker Journal: PLoS One Date: 2008-06-18 Impact factor: 3.240